The global medical industry experienced a 15% drop in company filings mentions of cybersecurity in Q2 2024 compared with the previous quarter, with the highest share accounted for by Steris with 245% year-on-year increase, according to GlobalData’s analysis of over 156 medical company filings. GlobalData’s Medical Devices: Filings Trends & Signals Q2 2024 report delves into earnings call transcripts and quarterly reports within the industry, extracting trends, signals, and comparative data to help businesses assess their performance, identify competitive intelligence, evaluate risks, and gain a comprehensive understanding of key industry events. Buy the report here.
Notably, cybersecurity was one of the most frequently referenced themes in Q2 2024, ranking highest in terms of mentions, ahead of environment and ecommerce, according to GlobalData.
Of the top leading companies in the medical industry, Steris had the greatest increase in references for cybersecurity in Q2 2024, compared with the previous quarter. GlobalData identified 38 cybersecurity-related sentences in the company's filings - 2% of all sentences - and an increase of 245% in Q2 2024 compared with Q2 2023. bioMerieux’s mentions of cybersecurity rose by 20% to 30 and Medtronic’s by 100% to 16 and Align Technology’s by 15% to 15 and Insulet’s by 46% to 13.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for cybersecurity in Q2 2024 was 124.
For further understanding of GlobalData's Medical Devices: Filings Trends & Signals Q2 2024, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.